The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Open accessAbstract
BACKGROUND: Despite best current therapy, up to 20% of pediatric patients with acute lymphoblastic leukemia (ALL) have a relapse. Recent genomewide analyses have identified a high frequency of DNA copy-number abnormalities in ALL, but the prognostic implications of these abnormalities have not been defined. METHODS: We studied a cohort of 221 children with high-risk B-cell-progenitor ALL with the use of single-nucleotide-polymorphism microarrays, transcriptional profiling, and resequencing of samples obtained at diagnosis. Children with known very-high-risk ALL subtypes (i.e., BCR-ABL1-positive ALL, hypodiploid ALL, and ALL in infants) were excluded from this cohort. A copy-number abnormality was identified as a predictor of poor outcome, and it was then tested in an independent validation cohort of 258 patients with B-cell-progenitor ALL. RESULTS: More than 50 recurring copy-number abnormalities were identified, most commonly involving genes that encode regulators of B-cell development (in 66.8% of patients in the original cohort); PAX5 was involved in 31.7% and IKZF1 in 28.6% of patients. Using copy-number abnormalities, we identified a predictor of poor outcome that was validated in the independent validation cohort. This predictor was strongly associated with alteration of IKZF1, a gene that encodes the lymphoid transcription factor IKAROS. The gene-expression signature of the group of patients with a poor outcome revealed increased expression of hematopoietic stem-cell genes and reduced expression of B-cell-lineage genes, and it was similar to the signature of BCR-ABL1-positive ALL, another high-risk subtype of ALL with a high frequency of IKZF1 deletion. CONCLUSIONS: Genetic alteration of IKZF1 is associated with a very poor outcome in B-cell-progenitor ALL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mice, both Ikzf1 and Ikzf3 are required for normal T cell development and maintenance of mature T cell populations88,89”
From Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide (2021) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan‐Smith, E., Dalton, J., Girtman, K., Mathew, S., Ma, J., Pounds, S. B., et al. (2007) · Nature · doi:10.1038/nature05690 · Cited by 1,777
Self-citationPui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Self-citationBCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Self-citationThe ikaros gene is required for the development of all lymphoid lineages
Georgopoulos, K., Bigby, M., Wang, J.-H., Molnar, A., Wu, P., Winandy, S., & Sharpe, A. (1994) · Cell · doi:10.1016/0092-8674(94)90407-3 · Cited by 985
Borowitz, M. J., Devidas, M., Hunger, S. P., Bowman, W. P., Carroll, A. J., Carroll, W. L., Linda, S. B., Martin, P. L., Pullen, D. J., Viswanatha, D. S., et al. (2008) · Blood · doi:10.1182/blood-2008-01-132837 · Cited by 841
Self-citationPrediction by Supervised Principal Components
Bair, E., Hastie, T. J., Paul, D., & Tibshirani, R. J. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000000628 · Cited by 824
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., Shurtleff, S. A., & Downing, J. R. (2008) · Science · doi:10.1126/science.1164266 · Cited by 806
Self-citationOn testing the significance of sets of genes
Efron, B., & Tibshirani, R. J. (2007) · The Annals of Applied Statistics · doi:10.1214/07-aoas101 · Cited by 785
Semi-Supervised Methods to Predict Patient Survival from Gene Expression Data
Bair, E., & Tibshirani, R. J. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020108 · Cited by 749
Flagged first, then by citations
Research works printed but not linked: 3
- Shuster JJ, 1999, Cancer Res Ther Control, 9, 101
- Pui CH, 2006, Ann Hematol, 85, 88
- Mirebeau D, 2006, Haematologica, 91, 881
Cited by
Sorted by citations
Items 401–500 of 1,000
Grunda, J. M., Steg, A. D., He, Q. P., Steciuk, M. R., Byan-Parker, S., Johnson, M. R., & Grizzle, W. E. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-248 · Cited by 42
BCR-ABL (Ph)-like acute leukemia—Pathogenesis, diagnosis and therapeutic options
Ofran, Y., & Izraeli, S. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.09.001 · Cited by 42
Benard-Slagter, A., Zondervan, I., de Groot, K., Ghazavi, F., Sarhadi, V. K., Vlierberghe, P. V., Moerloose, B. D., Schwab, C. J., Vettenranta, K. K., Harrison, C. J., et al. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.05.004 · Cited by 42
Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults
McNeer, J. L., & Bleyer, A. (2018) · Pediatric Blood & Cancer · doi:10.1002/pbc.26989 · Cited by 42
Gupta, S., Bakhshi, S., Kumar, L., Kamal, V. K., & Kumar, R. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2016.1193855 · Cited by 41
Copy-number analysis identified new prognostic marker in acute myeloid leukemia
Nibourel, O., Guihard, S., Roumier, C., Pottier, N., Terré, C., Paquet, A. C., Peyrouze, P., Geffroy, S., Quentin, S., Alberdi, A., et al. (2016) · Leukemia · doi:10.1038/leu.2016.265 · Cited by 41
Ding, Y., Zhang, B., Payne, J. L., Song, C., Ge, Z., Gowda, C. S., Iyer, S., Dhanyamraju, P. K., Dorsam, G. P., Reeves, M. E., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0474-0 · Cited by 41
Paugh, S. W., Stocco, G., McCorkle, J. R., Diouf, B., Crews, K. R., & Evans, W. E. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.126 · Cited by 41
Acute lymphoblastic leukaemia in children with Down syndrome: an updated review
Maloney, K. W. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08846.x · Cited by 41
Buchner, M., Swaminathan, S., Chen, Z., & Müschen, M. (2014) · Immunological Reviews · doi:10.1111/imr.12235 · Cited by 41
de Leeuw, N., Hehir‐Kwa, J. Y., Simons, A., van Kessel, A. G., Smeets, D., Faas, B. H. W., & Pfundt, R. (2011) · Cytogenetic and Genome Research · doi:10.1159/000331273 · Cited by 42
Behrmann, L., Eschenburg, G., Zech, A. T. L., Kriebitzsch, N., Otto, B., Streichert, T., Behlich, A.-S., Dierck, K., Klingler, B., Hansen, A., et al. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130497 · Cited by 42
Zhang, X., Rastogi, P., Shah, B. D., & Zhang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.19271 · Cited by 43
Genetic susceptibility in childhood acute lymphoblastic leukemia
Gutiérrez-Camino, Á., Martín‐Guerrero, I., & García‐Orad, Á. (2017) · Medical Oncology · doi:10.1007/s12032-017-1038-7 · Cited by 40
Berendsen, M. R., Stevens, W. B. C., van den Brand, M., van Krieken, J. H., & Scheijen, B. (2020) · Cancers · doi:10.3390/cancers12123553 · Cited by 40
Pathogenesis and prognostication in acute lymphoblastic leukemia
Zuckerman, T., & Rowe, J. M. (2014) · F1000Prime Reports · doi:10.12703/p6-59 · Cited by 40
High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia
Mu, Q., Wang, Y., Chen, B., Qian, W., Meng, H., Tong, H., Chen, F., Ma, Q., Ni, W., Chen, S., et al. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.05.012 · Cited by 39
Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma
Jahromi, M. S., Putnam, A. R., Druzgal, C. H., Wright, J. A., Spraker‐Perlman, H. L., Kinsey, M., Zhou, H., Boucher, K. M., Randall, R. L., Jones, K. B., et al. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.05.012 · Cited by 39
Béné, M. C., & Kaeda, J. (2009) · Haematologica · doi:10.3324/haematol.2008.004267 · Cited by 40
Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia
Yao, Q.-M., Liu, K., Gale, R. P., Jiang, B., Liu, Y., Jiang, Q., Jiang, H., Zhang, X., Zhang, M., Chen, S.-S., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2300-7 · Cited by 39
Kucine, N., Marubayashi, S., Bhagwat, N., Papalexi, E., Koppikar, P., Martin, M. S., Dong, L., Tallman, M. S., Paietta, E. M., Wang, K., et al. (2015) · Blood · doi:10.1182/blood-2015-03-635821 · Cited by 39
Self-citationBlocking promiscuous activation at cryptic promoters directs cell type–specific gene expression
Kim, J., Lu, C., Srinivasan, S., Awe, S., Brehm, A., & Fuller, M. T. (2017) · Science · doi:10.1126/science.aal3096 · Cited by 39
The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia
Shiraz, P., Payne, K. J., & Muffly, L. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062193 · Cited by 39
The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia
Zhang, X., Zhang, X., Li, X., Lv, Y., Zhu, Y., Wang, J., Jin, J., & Yu, W. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00972-5 · Cited by 39
Downes, C. E. J., McClure, B. J., McDougal, D. P., Heatley, S. L., Bruning, J. B., Thomas, D., Yeung, D. T. O., & White, D. L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.942053 · Cited by 38
Gao, Q., Ryan, S. L., Iacobucci, I., Ghate, P. S., Cranston, R. E., Schwab, C. J., Elsayed, A. H., Shi, L. G., Pounds, S. B., Lei, S., et al. (2023) · Blood · doi:10.1182/blood.2022019094 · Cited by 41
Self-citationLineage-specific 3D genome organization is assembled at multiple scales by IKAROS
Hu, Y.-G., Figueroa, D. S., Zhang, Z., Veselits, M. L., Bhattacharyya, S., Kashiwagi, M., Clark, M. R., Morgan, B. A., Ay, F., & Georgopoulos, K. (2023) · Cell · doi:10.1016/j.cell.2023.10.023 · Cited by 36
Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
Schwab, C. J., Nebral, K., Chilton, L., Leschi, C., Waanders, E., Boer, J. M., Zaliova, M. K., Sutton, R., Öfverholm, I. I., Ohki, K., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017006734 · Cited by 38
Biology of Childhood Acute Lymphoblastic Leukemia
Nigro, L. L. (2013) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31828f8746 · Cited by 38
Novel Therapies in Acute Lymphoblastic Leukemia
Phelan, K. W., & Advani, A. S. (2018) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-018-0457-7 · Cited by 41
Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia
Awad, S. A., Kankainen, M., & Mustjoki, S. M. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1894652 · Cited by 39
Mangum, D. S., Downie, J. M., Mason, C. C., Jahromi, M. S., Joshi, D., Rodic, V., Müschen, M., Meeker, N. D., Trede, N. S., Frazer, J. K., et al. (2013) · Leukemia · doi:10.1038/leu.2013.223 · Cited by 38
Self-citationGadd, S., Beezhold, P., Jennings, L. J., George, D. W., Leuer, K., Huang, C., Huff, V., Tognon, C. E., Sorensen, P. H. B., Triche, T. J., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4010 · Cited by 38
Gowda, C. S., Song, C., Kapadia, M. A., Payne, J. L., Hu, T., Ding, Y., & Dovat, S. (2016) · Advances in Biological Regulation · doi:10.1016/j.jbior.2016.09.003 · Cited by 37
Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome
Witkowski, M. T., Hu, Y., Roberts, K. G., Boer, J. M., McKenzie, M. D., Liu, G. J., Grice, O., Tremblay, C. S., Ghisi, M., Willson, T. A., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160048 · Cited by 37
Self-citationGenetic abnormalities associated with acute lymphoblastic leukemia
Yokota, T., & Kanakura, Y. (2016) · Cancer Science · doi:10.1111/cas.12927 · Cited by 37
Chen, D., Zheng, J., Gerasimčik, N., Lagerstedt, K., Sjögren, H., Abrahamsson, J., Fogelstrand, L., & Mårtensson, I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162638 · Cited by 38
Arenzana, T. L., Schjerven, H., & Smale, S. T. (2015) · Genes & Development · doi:10.1101/gad.266999.115 · Cited by 37
Coustan‐Smith, E., & Campana, D. (2010) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2010.07.007 · Cited by 36
Self-citationGenomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia
Pui, C. (2014) · Frontiers of Medicine · doi:10.1007/s11684-015-0381-3 · Cited by 36
Self-citationEZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia
Schäfer, V., Ernst, J., Rinke, J., Winkelmann, N., Beck, J. F., Hochhaus, A., Gruhn, B., & Ernst, T. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2174-8 · Cited by 36
How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia
Frisch, A., & Ofran, Y. (2019) · Haematologica · doi:10.3324/haematol.2018.207506 · Cited by 36
Lee, S. H. R., Li, Z., Tai, S. T., Oh, B. L. Z., & Yeoh, A. E. J. (2021) · Cancers · doi:10.3390/cancers13164068 · Cited by 36
Kim, R., Bergugnat, H., Larcher, L., Duchmann, M., Passet, M., Gachet, S., Cuccuini, W., Lafage‐Pochitaloff, M., Pastoret, C., Grardel, N., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0154 · Cited by 39
Tokunaga, K., Yamaguchi, S., Iwanaga, E., Nanri, T., Shimomura, T., Suzushima, H., Mitsuya, H., & Asou, N. (2013) · European Journal Of Haematology · doi:10.1111/ejh.12155 · Cited by 36
Burke, M. J., Gossai, N. P., Wagner, J. E., Smith, A. R., Bachanová, V., Cao, Q., MacMillan, M. L., Stefanski, H., Weisdorf, D. J., & Verneris, M. R. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2012.08.020 · Cited by 36
Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease
Toubai, T., Sun, Y., Tawara, I., Friedman, A. D., Liu, C., Evers, R., Nieves, E. C., Malter, C., Chockley, P. J., Maillard, I. P., et al. (2011) · Blood · doi:10.1182/blood-2010-12-324616 · Cited by 35
Recurrent Cytogenetic Abnormalities in Acute Lymphoblastic Leukemia
Shago, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6703-2_21 · Cited by 34
Janczar, S., Janczar, K., Pastorczak, A. K., Harb, H., Paige, A. J. W., Zalewska‐Szewczyk, B., Danilewicz, M., & Mlynarski, W. M. (2017) · Cancers · doi:10.3390/cancers9010002 · Cited by 36
Sutton, R., Venn, N. C., Law, T., Boer, J. M., Trahair, T. N., Ng, A., den Boer, M. L., Dissanayake, D. R. A., Giles, J. E., Dalzell, P., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.15056 · Cited by 34
Lazaryan, A., Dolan, M., Zhang, M., Wang, H., Kharfan‐Dabaja, M. A., Marks, D. I., Bejanyan, N., Copelan, E. A., Majhail, N. S., Waller, E. K., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.220756 · Cited by 34
Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia
Aberuyi, N., Rahgozar, S., Ghodousi, E. S., & Ghaedi, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01496 · Cited by 34
Application of precision medicine in clinical routine in haematology—Challenges and opportunities
Wästerlid, T., Cavelier, L. B., Haferlach, C., Konopleva, M. Y., Fröhling, S., Östling, P., Bullinger, L., Fioretos, T., & Smedby, K. E. E. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13508 · Cited by 35
Abbas, S., Sanders, M. A., Zeilemaker, A., Geertsma-Kleinekoort, W. M. C., Koenders, J. E., Kavelaars, F. G., Abbas, Z. G., Mahamoud, S., Chu, I. W. T., Hoogenboezem, R. M., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.095604 · Cited by 34
Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults
Khaled, S. K., Thomas, S. H., & Forman, S. J. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834f5c41 · Cited by 34
Rhein, P., Mitlöhner, R., Basso, G., Gaipa, G., Dworzak, M. N., Kirschner‐Schwabe, R., Hagemeier, C., Stanulla, M., Schrappe, M., Ludwig, W.-D., et al. (2010) · Blood · doi:10.1182/blood-2009-10-247585 · Cited by 34
Transcriptional regulation of the Ikzf1 locus
Yoshida, T., Landhuis, E. W.-Y., Dose, M., Hazan, I., Zhang, J., Naito, T., Jackson, A. F., Wu, J. H., Perotti, E. A., Kaufmann, C., et al. (2013) · Blood · doi:10.1182/blood-2013-01-474916 · Cited by 33
Self-citationHuguet, F., Leguay, T., Raffoux, E., Rousselot, P. H., Vey, N., Pigneux, A., Ifrah, N., & Dombret, H. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.887708 · Cited by 33
Ge, Z., Gu, Y., Xiao, L., Han, Q., Li, J., Chen, B., Yu, J. B., Kawasawa, Y. I., Payne, K. J., Dovat, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10014 · Cited by 33
Lenk, L., Carlet, M., Vogiatzi, F., Spory, L., Winterberg, D., Cousins, A., Vossen‐Gajcy, M., Ibruli, O., Vokuhl, C., Cario, G., et al. (2021) · Communications Biology · doi:10.1038/s42003-020-01591-z · Cited by 33
Raca, G., Abdel‐Azim, H., Yue, F., Broach, J. R., Payne, J. L., Reeves, M. E., Gowda, C. S., Schramm, J. W., Desai, D. H., Dovat, E., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01133-4 · Cited by 33
Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia
Lilljebjörn, H., Orsmark‐Pietras, C., Mitelman, F., Andersson, A., & Fioretos, T. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.013 · Cited by 33
Burke, M. J., Devidas, M., Chen, Z., Salzer, W. L., Raetz, E. A., Rabin, K. R., Heerema, N. A., Carroll, A. J., Gastier, J. M., Borowitz, M. J., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01460-6 · Cited by 33
Self-citationGenetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
Xu, H., Yu, H., Jin, R., Wu, X., & Chen, H. (2021) · Cells · doi:10.3390/cells10123349 · Cited by 33
Grunda, J. M., Fiveash, J. B., Palmer, C. A., Cantor, A. B., Fathallah‐Shaykh, H. M., Nabors, B., & Johnson, M. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3151 · Cited by 33
Hochberg, J. C., Khaled, S. K., Forman, S. J., & Cairo, M. S. (2013) · British Journal of Haematology · doi:10.1111/bjh.12239 · Cited by 32
Baughn, L. B., Biegel, J. A., South, S. T., Smolarek, T. A., Volkert, S., Carroll, A. J., Heerema, N. A., Rabin, K. R., Zweidler‐McKay, P. A., Loh, M. L., et al. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.11.003 · Cited by 32
Linabery, A. M., Blommer, C. N., Spector, L. G., Davies, S. M., Robison, L. L., & Ross, J. A. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.04.022 · Cited by 32
Mayfield, J. R., Czuchlewski, D. R., Gale, J. M., Matlawska‐Wasowska, K., Vasef, M. A., Nickl, C. K., Pickett, G., Ness, S. A., & Winter, S. S. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26328 · Cited by 32
Nardi, V., Ku, N. C., Frigault, M. J., Dubuc, A. M., Tsai, H. K., Amrein, P. C., Hobbs, G. S., Brunner, A. M., Narayan, R., Burke, M. E., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000769 · Cited by 32
Böhm, J. W., Sia, K. C. S., Jones, C. D., Evans, K., Mariana, A., Pang, C. N. I., Failes, T. W., Zhong, L., Mayoh, C., Landman, R. R., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01248-8 · Cited by 32
Geron, I., Savino, A. M., Fishman, H., Tal, N., Brown, J., Turati, V. A., James, C. T., Sarno, J., Hameiri-Grossman, M., Lee, Y. N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28218-7 · Cited by 33
Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies
Fukuhara, S., Oshikawa‐Kumade, Y., Kogure, Y., Shingaki, S., Kariyazono, H., Kikukawa, Y., Koya, J., Saito, Y., Tabata, M., Yoshifuji, K., et al. (2022) · Cancer Science · doi:10.1111/cas.15427 · Cited by 32
Short, N. J., Kantarjian, H. M., Furudate, K., Jain, N., Ravandi, F., Karrar, O. S., Loghavi, S., Nasr, L. F., Haddad, F., Senapati, J., et al. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01709-y · Cited by 31
Signaling Proteins and Transcription Factors in Normal and Malignant Early B Cell Development
Pérez‐Vera, P., Reyes-León, A., & Fuentes‐Pananá, E. M. (2011) · Bone Marrow Research · doi:10.1155/2011/502751 · Cited by 31
Novel therapy for childhood acute lymphoblastic leukemia
Santiago, R., Vairy, S., Sinnett, D., Krajinović, M., & Bittencourt, H. N. D. S. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1340938 · Cited by 31
Why and how to treat Ph-like ALL?
Roberts, K. G. (2018) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2018.09.003 · Cited by 31
Mehta, P. A., Rotz, S. J., & Majhail, N. S. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.09.011 · Cited by 31
Niedźwiecki, M., Budziło, O., Adamkiewicz-Drożyńska, E., Pawlik-Gwozdecka, D., Zieliński, M., Maciejka-Kembłowska, L., Szczepański, T., & Trzonkowski, P. (2019) · Journal of Immunology Research · doi:10.1155/2019/2816498 · Cited by 31
The evolution of relapse of adult T cell acute lymphoblastic leukemia
Sentís, I., González, S., Genescà, E., García‐Hernández, V., Muiños, F., González‐Gil, C., López‐Arribillaga, E., González, J., Fernández‐Ibarrondo, L., Mularoni, L., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02192-z · Cited by 35
González‐Gil, C., Ribera, J., Ribera, J., & Genescà, E. (2021) · Genes · doi:10.3390/genes12010079 · Cited by 32
Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice
Thomas, K. R., Allenspach, E. J., Camp, N. D., Wray-Dutra, M. N., Khim, S., Zielinska‐Kwiatkowska, A., Timms, A. E., Loftus, J. P., Liggitt, H. D., Georgopoulos, K., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01326-x · Cited by 31
Izraeli, S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08312.x · Cited by 31
Highly sensitive MRD tests for ALL based on the IKZF1 Δ3–6 microdeletion
Venn, N. C., van der Velden, V. H. J., de Bie, M., Waanders, E., Giles, J. E., Law, T., Kuiper, R. P., de Haas, V., Mullighan, C. G., Haber, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.348 · Cited by 31
Self-citationContext-specific roles for paracrine IL-6 in lymphomagenesisPreprint
Gilbert, L. A., & Hemann, M. T. (2012) · Genes & Development · doi:10.1101/gad.197590.112 · Cited by 31
Witkowski, M. T., Cimmino, L., Hu, Y., Trimarchi, T., Tagoh, H., McKenzie, M. D., Best, S. A., Tuohey, L., Willson, T. A., Nutt, S. L., et al. (2015) · Leukemia · doi:10.1038/leu.2015.27 · Cited by 30
Novel targeted drug therapies for the treatment of childhood acute leukemia
Brown, P. A., Hunger, S. P., Smith, F. O., Carroll, W. L., & Reaman, G. H. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.1 · Cited by 30
Self-citationDougherty, M. J., Wilmoth, D. M., Tooke, L. S., Shaikh, T. H., Gai, X., Hakonarson, H. H., & Biegel, J. A. (2011) · Cancer Genetics · doi:10.1016/j.cancergencyto.2010.10.007 · Cited by 30
An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpression
Yano, M., Imamura, T., Asai, D., Moriya‐Saito, A., Suenobu, S., Hasegawa, D., Deguchi, T., Hashii, Y., Kawasaki, H., Hori, H., et al. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22190 · Cited by 30
Kuehn, H. S., Nunes-Santos, C. J., & Rosenzweig, S. D. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1901582 · Cited by 30
Creasey, T., Barretta, E., Ryan, S. L., Butler, E. R., Kirkwood, A. A., Leongamornlert, D. A., Papaemmanuil, E., Patrick, P., Clifton‐Hadley, L., Patel, B. G., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.279177 · Cited by 30
Migita, N. A., Jotta, P. Y., do Nascimento, N. P., Vasconcelos, V. S., Centoducatte, G. L., Massirer, K. B., de Azevedo, A. C., Brandalise, S. R., & Yunes, J. A. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022009179 · Cited by 30
Asai, D., Imamura, T., Yamashita, Y. I., Suenobu, S., Moriya‐Saito, A., Hasegawa, D., Deguchi, T., Hashii, Y., Endo, M., Hatakeyama, N., et al. (2014) · Cancer Medicine · doi:10.1002/cam4.221 · Cited by 30
Asanuma, S., Yamagishi, M., Kawanami, K., Nakano, K., Sato‐Otsubo, A., Muto, S., Sanada, M., Yamochi, T., Kobayashi, S., Utsunomiya, A., et al. (2013) · Cancer Science · doi:10.1111/cas.12181 · Cited by 30
Kobitzsch, B., Gökbuget, N., Schwartz, S., Reinhardt, R., Brüggemann, M., Viardot, A., Wäsch, R., Starck, M., Thiel, E., Hoelzer, D. F., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.161273 · Cited by 30
Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia
Rafei, H., Kantarjian, H. M., & Jabbour, E. J. (2019) · British Journal of Haematology · doi:10.1111/bjh.16207 · Cited by 32
Harrison, C. J. (2011) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2011.08.016 · Cited by 31
Usvasalo, A., Ninomiya, S., Räty, R., Hollmén, J., Saarinen‐Pihkala, U. M., Elonen, E., & Knuutila, S. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20741 · Cited by 29
The role of Pax5 in leukemia: diagnosis and prognosis significance
Shahjahani, M., Norozi, F., Ahmadzadeh, A., Shahrabi, S., Tavakoli, F., Asnafi, A. A., & Saki, N. (2014) · Medical Oncology · doi:10.1007/s12032-014-0360-6 · Cited by 29
Genomic analysis of acute leukemia
Mullighan, C. G. (2009) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2009.01167.x · Cited by 29
Self-citation
Metadata
- Authors
- Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., Harvey, R. C., Chen, I.-M., Clifford, R. J., Carroll, W. L., Reaman, G., Bowman, W. P., Devidas, M., Gerhard, D. S., Yang, W., Relling, M. V., Shurtleff, S. A., Campana, D., Borowitz, M. J., Pui, C.-H., Smith, M., Hunger, S. P., Willman, C. L., & Downing, J. R.
- Affiliations
- St. Jude Children's Research Hospital (US)
- National Institutes of Health (US)
- UNM Comprehensive Cancer Center (US)
- New York University (US)
- Children's National (US)
- Cook Children's Medical Center (US)
- University of Florida Health (US)
- Children's Hospital Colorado (US)
- ORCID
- Mullighan, Charles G.
- Su, Xiaoping
- Zhang, Jinghui
- Radtke, Ina
- Ma, Jing
- Liu, Wei
- Cheng, Cheng
- Schulman, Brenda A.
- Harvey, Richard C.
- Chen, I-Ming
- Clifford, Robert J.
- Carroll, William L.
- Reaman, Gregory
- Bowman, W. Paul
- Devidas, Meenakshi
- Yang, Wenjian
- Relling, Mary V.
- Campana, Dario
- Pui, Ching-Hon
- Smith, Malcolm
- Hunger, Stephen P.
- Willman, Cheryl L.
- Downing, James R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-01-29
- Volume
- 360
- Issue
- 5
- Pages
- 470-480
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2674612
- OpenAlex
- W2040329520
- Cited by
- 1,422
- References
- 37
- Citations by year
- 2026: 30 · 2025: 50 · 2024: 66 · 2023: 90 · 2022: 66 · 2021: 103 · 2020: 92 · 2019: 69 · 2018: 74 · 2017: 105 · 2016: 96 · 2015: 101 · 2014: 84 · 2013: 90 · 2012: 98
- FWCI
- 101.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service (N01C012400, 21765)
- National Cancer Institute (CA 098543, R01CA086011, U10CA098413, U01CA157937, R01 CA86011, U10CA098543, U01CA114762, CA114762, P30CA021765)
- National Institute of General Medical Sciences (U01 GM61393, U01GM061374, U01-GM-61374, U01GM061393)
- Topics
- Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- IKZF1 deletion, acute lymphoblastic leukemia, pediatric leukemia, copy number abnormalities, prognosis, PAX5, Ikaros, B cell development, gene expression signatures, relapse
- MeSH terms
- B-Lymphocytes, Child, DNA Mutational Analysis, Genotype, Hematopoietic Stem Cells, Humans, Prognosis, Recurrence, Cohort Studies, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Trans-Activators, Gene Expression, Treatment Outcome, Gene Deletion, Drug Resistance, Neoplasm, Mutation, Missense, Gene Expression Profiling, Ikaros Transcription Factor, PAX5 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
